The clinical effectiveness and costeffectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: A systematic review

  1. Fleeman, N.
  2. Saborido, C.M.
  3. Payne, K.
  4. Boland, A.
  5. Dickson, R.
  6. Dundar, Y.
  7. Santander, A.F.
  8. Howell, S.
  9. Newman, W.
  10. Oyee, J.
  11. Walley, T.
Revue:
Health Technology Assessment

ISSN: 1366-5278

Année de publication: 2011

Volumen: 15

Número: 33

Pages: 1-102

Type: Révision

DOI: 10.3310/HTA15330 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus